The Kraft Heinz KHC
Consumer Defensive · Packaged Foods · Synthos Deep Dive · 2026-07-03
The Overview
Kraft Heinz makes the food in your pantry — Heinz ketchup, Kraft mac & cheese, Philadelphia cream cheese, Oscar Mayer, Jell-O, Lunchables, Capri Sun. It is a huge, stable, boring company that throws off a lot of cash and pays a big dividend (about 6% a year).
The stock looks cheap — you pay about $12 for every $1 of expected yearly profit, roughly half what the average big stock costs. But cheap can be a trap. Sales have fallen three years in a row, shoppers are trading down to cheaper store brands, and in 2025 the company admitted its famous brands are worth $9 billion less than it thought and took a giant write-off. Management is even splitting the company in two to try to fix it.
Our verdict is Watch — not "buy," not "sell." The dividend and cheapness are real, but so is the shrinkage. You'd be paid ~6% a year to wait and see if management can stop the bleeding.
Here's what our three scores mean in everyday terms:
- Downside Risk 6/10 (a bit above average). The stock barely moves day-to-day and gushes cash, which is safe — but it carries a lot of debt relative to its shrinking profits, and it has already fallen ~43% from its peak.
- Growth Quality 3/10 (poor). This business is slowly getting smaller, not bigger. That's the core problem.
- Exponential Potential 1/10 (essentially none). A mature ketchup-and-cheese company is the opposite of a fast-growing tech name. Don't expect the stock to multiply.
The one big worry: the classic "value trap" — a cheap stock with a fat dividend that just keeps drifting lower because the underlying business keeps shrinking.
Putting a number on it: our fair-value estimate is $25 against a current price of $25.70 — a premium price for a business we still like.
Our summary metrics
Low beta (0.08) & 13% FCF yield cushion, but ~7× net-debt/EBITDA, a −43% drawdown and a $9B+ FY25 brand impairment flag value-trap risk.
Revenue shrinking (~$26.6B→$24.9B in 2 yrs), flat ~$2.05–2.25 EPS to 2030, negative ROIC on impaired capital — a melting ice cube, not a compounder.
No acceleration and no room-to-run — a mature, decelerating packaged-food name; the opposite of exponential.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
No acceleration and no room-to-run — a mature, decelerating packaged-food name; the opposite of exponential.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $22.70 (high $25 / low $18; median $23; 0 Strong-Buy · 4 Buy · 20 Hold · 11 Sell) — below the current price |
| Valuation | GAAP loss (FY25 EPS −$4.93, impairment) · 12.3× FY26E · 12.2× FY27E · 11.3× FY30E · EV/S 1.9× · P/FCF 7.6× · FCF yield ~13% · div yield ~6.3% |
| Technicals | Weak/basing — $25.37, −12% off 52-wk high, above 50/200-DMA, RSI 58, −4.7% 12-mo (SPY +21%, QQQ +30%) |
| Conviction | Low — 0 net-bullish voices, 0 reconciled claims; verdict rests on fundamentals + quant only |
| Position sizing | If owned at all: income/value satellite ≤2–3%, not a core holding |
What the experts actually said
No independent expert claims in the Synthos knowledge base yet for KHC — this dive is fundamentals- and technicals-driven, not panel-driven.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $25.70, 2% above the 50-day average ($25), 7% above the 200-day average ($24) — an uptrend. 8% below the 52-week high of $28, 21% above the 52-week low of $21.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $25.70 is currently inside the band (band $24–$26).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 53.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently below its signal line by 0.02, negative momentum.
Relative performance vs S&P 500 & its sector (XLP (sector)), set to 100 a year ago
Solid = KHC · dashed = S&P 500 · dotted = XLP (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
Kraft Heinz (Nasdaq: KHC) is a global packaged-food and beverage company formed by the 2015 merger of Kraft and H.J. Heinz (Heinz itself dates to 1869). It sells condiments and sauces, cheese and dairy, prepared/ready meals, meats, coffee, snacks, and beverages through grocery, club, convenience, foodservice, and e-commerce channels. HQ in Pittsburgh; CEO Steven A. Cahillane; ~36,000 employees. Fiscal year ends late December.
Revenue mix (FY2025, from filings):
- By product category: Taste Elevation (condiments & sauces — the Heinz core) $11.28B (45%) · Easy Ready Meals $4.07B · Hydration $2.10B · Meats $1.92B · Cheese & Dairy $1.66B · Substantial Snacking $1.53B · Desserts/Toppings/Baking $1.12B · Coffee $0.87B · Other $0.40B. (Note: KHC re-mapped its category taxonomy in 2024–25, so year-over-year category lines are not clean comparables.)
- By geography: United States $16.78B (67%) · Rest of World $5.09B · Canada $1.80B · United Kingdom $1.27B. US-concentrated — exposure to US grocery/private-label competition and consumer trade-down.
The strategic story of the moment: in 2025 the company began a planned separation into two independent companies (a "Global Taste Elevation" sauces/condiments business and a North American grocery business) — an admission that the merged conglomerate has not delivered synergies and that the crown-jewel Heinz franchise deserves a cleaner story. (Corporate action; not a Synthos KB claim.)
2. The expert thesis — no expert coverage
There is no expert coverage of KHC in the Synthos knowledge base. The claims file returns total_claims: 0, net_bullish_voices: 0, and an empty top array. No independent voice in our panel — bullish or bearish — has made a traceable, dated claim on this name.
What that means for this note: the verdict is entirely fundamentals- and quant-driven. There is no conviction-track signal to lean on, and (per house standard) we will not manufacture one. Every judgment below is anchored to FMP financials, analyst estimates, and price data — not to expert claims, because there are none to cite. Absence of coverage is itself mildly informative: KHC is not a name the growth/quality-oriented voices in our KB are talking about, consistent with its low-growth profile.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 6 · Moderate-High | Beta 0.08 and ~13% FCF yield cushion the stock, but net-debt/EBITDA is ~7× on FY26E EBITDA, the shares are −43% from peak, and FY25's $9B+ brand impairment says the asset base was overstated. Cheap ≠ safe when the business shrinks. |
| Growth Quality | 3 · Poor | Revenue fell $26.6B→$25.8B→$24.9B (FY23→FY25) and consensus has it flat-to-down to ~$24.5–25.0B through 2030; EPS stuck at ~$2.05→$2.25. TTM ROIC/ROE are negative on impaired capital. A melting-ice-cube, not a compounder. |
| Exponential Potential | 1 · Very low | Forward growth is ~0% with a negative acceleration trend; a $30B mature packaged-food name in a low-single-digit-growth category has no room-to-run. The structural opposite of an exponential. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | The two-way split unlocks a re-rating: Heinz/Taste Elevation gets a higher multiple, volumes stabilize, private-label pressure eases. FY27E EPS ~$2.15 holds; multiple re-rates to ~15× (peer-average). | ~$33 (+30%) |
| Base (our anchor) | Estimates roughly hit — FY27E EPS ~$2.07, revenue flat ~$24.5B. A no-growth but cash-rich name earns a ~12× multiple (in line with today). Dividend does the work; price roughly flat. | ~$25 (~flat) |
| Bear | Trade-down and private label keep eroding volume; a further brand impairment; dividend gets questioned as net-debt/EBITDA stays elevated. FY27E EPS slips to ~$1.85; multiple de-rates to ~9×. | ~$17 (−33%) |
Synthos fair value = the base case, ~$25 (roughly flat vs the $25.37 price), with the full $17–$33 span as the honest range. Note our base sits above the Street's $22.70 consensus — but that is not a bullish tell: the Street's average target is below the current price, i.e. the sell side thinks KHC is modestly overvalued here. Our roughly-flat base plus a ~6% dividend is a "get paid to wait" case, not an appreciation case. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). KHC is neither — it is a mature, cash-harvesting franchise in slow structural decline:
- Forward growth: revenue CAGR FY25→FY30E ≈ 0% ($24.9B → ~$25.0B); EPS CAGR ≈ +1.9% ($2.06 FY26E → $2.25 FY30E) — and that modest EPS drift comes from buybacks/mix, not volume.
- Acceleration (the 2nd derivative) is negative: revenue went −0.6% (FY24) → −3.5% (FY25) and consensus keeps it flat-to-down. There is no inflection to point to; the trend is deceleration, not acceleration.
- Room to run: the US packaged-food TAM is enormous but low-growth and hotly contested by private label; a $30B incumbent with 67% US exposure has no untapped runway that would drive a multibagger. Room-to-run is effectively nil.
- Reinvestment runway: capex is modest (~$0.8B, 3% of revenue) and reinvestment opportunities are limited — this is a cash-return story (dividend + buyback), not a cash-reinvestment story.
Exponential Potential: Very low (1/10). Own KHC, if at all, for income and a possible value/split re-rating — never for growth. This honest framing is why KHC cannot sit in a growth or "next-exponential" sleeve.
5. Financials (real numbers — FMP annual/quarterly)
- Revenue: FY25 $24.94B, −3.5% (FY24 $25.85B, −3.0% on FY23 $26.64B). Three straight years of decline — the central problem.
- The FY25 impairment: GAAP net income was −$5.85B (EPS −$4.93), driven almost entirely by a ~$9B+ non-cash goodwill/intangible brand impairment (visible as +$9.5B "other non-cash items" in operating cash flow, and Q2'25's −$7.8B EBITDA print). Goodwill fell $28.7B→$22.2B and intangibles $40.1B→$37.5B year-over-year. This is an accounting write-down of brand value, not a cash loss — but it is a real signal that the brands are worth less than the balance sheet claimed.
- Underlying earnings power (ex-impairment): the cash business is intact — Q1'26 EPS $0.67, Q4'25 $0.55, and adjusted quarterly EBITDA runs ~$1.3–1.5B. Consensus adjusted EPS ~$2.05 (FY26E).
- Margins: gross ~33% (structurally lower than branded-food peers), and on an adjusted basis EBITDA margin ~10–11%. GAAP margins are distorted by the impairment.
- Cash flow (the bull's best point): operating CF $4.46B, capex −$0.80B, FCF $3.66B FY25 — a ~13% FCF yield at today's price. FCF comfortably covered the $1.90B dividend and $0.44B buyback.
- Balance sheet: total debt $21.2B, net debt $18.6B. On FY26E EBITDA (~$2.6B) that is ~7× net-debt/EBITDA — high; on an adjusted ~$3.5–4B EBITDA basis it's closer to ~5×. Either way, leverage is meaningful and constrains flexibility. FMP letter rating B−, overall score 2/5.
6. Valuation — cheap, or a trap?
On forward numbers KHC screens cheap: 12.3× FY26E EPS, 12.2× FY27E, 11.3× FY30E, EV/sales 1.9×, P/FCF 7.6×, a ~13% free-cash-flow yield and a ~6.3% dividend yield. Trailing GAAP P/E is meaningless (negative, from the impairment). The bear's rebuttal is that the multiple is low for a reason: you can't grow a DCF that isn't growing, and a ~7× net-debt/EBITDA balance sheet plus a $9B brand write-down argue the discount is earned, not a mispricing. The price-to-fair-value screen (0.72×) and P/B (0.72×) say the market values equity below stated book — but stated book is inflated by ~$60B of goodwill+intangibles, so a sub-1× P/B is not obviously a bargain. Street targets (context): consensus $22.70, high $25, low $18, median $23 — the average target sits below the $25.37 price, and grades skew cautious (0 Strong-Buy, 4 Buy, 20 Hold, 11 Sell). This is not a value screen we'd chase; it is a "get paid ~6% to wait for the split to prove itself" situation.
7. Technicals (from the tech block)
- Trend: mildly constructive but weak. $25.37 sits above the 50-DMA ($23.29) and 200-DMA ($23.98) — a recent bounce off a depressed base, MACD slightly positive (+0.30).
- Location: −12.3% off the 52-week high ($28.94) and +19.6% off the 52-week low ($21.21). The longer-term picture is ugly: max drawdown −43% from peak — this stock has destroyed capital over multiple years.
- Momentum: RSI(14) 58 — neutral, neither oversold nor overbought.
- Relative strength (the tell): KHC −4.7% over 12 months while SPY was +20.6% and QQQ +30.3% — brutal underperformance of both the market and the Nasdaq-100 it belongs to. The 3-month bounce (+13.9%, roughly matching SPY) is a rebound within a long downtrend, not a confirmed reversal.
- Read: technicals are basing above rising short-term averages but inside a multi-year downtrend. No urgency; a defensible entry would want to see revenue stabilize before trusting the bounce.
8. Moat & competitive position
KHC's moat is brand and distribution scale: Heinz, Kraft, Philadelphia, Oscar Mayer, Jell-O, Capri Sun, Lunchables are category-defining names with shelf presence few can match, and condiments/sauces (Taste Elevation, 45% of revenue) is the genuinely durable, higher-margin core. But the moat is eroding at the edges: private-label/store brands are taking share as consumers trade down, several legacy grocery categories (cheese, cold cuts, packaged meals) are low-growth and price-competitive, and the FY25 impairment is management conceding brand equity has weakened. The planned two-way split is an attempt to isolate the strong Heinz moat from the weaker grocery portfolio.
Peer set (market cap): Kenvue $38B, Kellanova $29B, General Mills $20B, McCormick $14.4B, J.M. Smucker $12.4B, Archer-Daniels-Midland $37B, Estée Lauder $30.3B, Ambev $48.3B, JBS $27.2B. Against branded-food peers (GIS, K, MKC, SJM), KHC trades at a discount multiple — appropriate given its worse revenue trajectory and higher leverage.
9. Management, capital allocation & guidance
- Capital allocation: a cash-return model — ~$1.9B/yr dividend (covered ~1.9× by FCF) plus modest buybacks (~$0.44B). Capex is light (~$0.8B). The dividend has been held flat (last declared $1.60/yr), and coverage on cash is adequate even though GAAP EPS is negative post-impairment. The strategic centerpiece is the planned separation into two companies — a portfolio-simplification / value-unlock move.
- Insider activity: the sampled window shows routine director stock awards (May 2026, ~$23.31) and one small officer open-market sale (Chief Growth Officer, 18,502 shares at ~$23.05, filed 2026-06-22). Nothing that reads as an alarming cluster; awards dominate.
- Guidance caveat: no management claims are ingested into the Synthos KB for KHC. Forward figures here are analyst consensus (FMP), labeled as estimates — not company guidance and not expert conviction.
10. Catalysts & what to watch
- Next earnings: 2026-07-29 (Q2'26; Street EPS $0.53, revenue ~$6.11B). Watch organic volume vs price — is the decline volume-led (bad) or a lapping effect (less bad)?
- The two-way split: structure, timing, debt allocation, and the standalone multiples the market assigns to Heinz vs the grocery business — the single biggest swing factor for the bull case.
- Private-label share trend: the secular threat; any sign of stabilization would matter.
- Dividend durability: at ~6.3% yield with ~7× net-debt/EBITDA, watch FCF coverage and any commentary on the payout through the split.
- Further impairment risk: after FY25's $9B write-down, another would signal the erosion is ongoing.
Thesis tripwires (what would change the call): revenue decline accelerating past mid-single digits; a dividend cut or suspension; a second brand impairment; or the split being delayed/abandoned. Conversely, two quarters of stabilizing organic volume + a credible split path would justify upgrading from Watch.
11. Key risks
- Value trap (the central risk): a cheap multiple and fat yield that keep re-rating down as volumes and brand equity erode — the −43% multi-year drawdown is the warning.
- Secular / private label: consumer trade-down to store brands structurally pressures a 67%-US-exposed grocery portfolio.
- Leverage: ~$18.6B net debt, ~7× FY26E EBITDA, B− rating — limits flexibility and puts the dividend under scrutiny in a downturn.
- Brand impairment signal: FY25's $9B+ write-down says the assets were overstated; more could follow.
- Split execution: the separation could disappoint on timing, dis-synergies, or debt allocation.
- No expert coverage: we have zero KB voices to corroborate or challenge the thesis — conviction is structurally low here by design.
12. Verdict, position sizing & monitoring
Watch. KHC is a genuinely cheap, cash-generative, 6%-yielding franchise — but it is shrinking, levered, and just wrote down $9B of brand value, the Street's average target sits below the price, and it has trailed the market by ~25 points over the past year. That is the textbook profile of a value trap until proven otherwise. There is no expert coverage in the Synthos KB, so we lean entirely on fundamentals and quant, and both say: interesting for income, not yet a buy for total return.
- Sizing: if owned at all, an income/value satellite ≤2–3% — never a core or growth position. The ~6% dividend is the reason to hold; the shrinkage is the reason to keep it small.
- Monitoring: re-underwrite on the §10 tripwires; formal re-score at the 2026-07-29 print and on any split milestone. Upgrade path = stabilizing organic volume + a credible, value-accretive split. Downgrade path = dividend cut or accelerating decline.
- Single biggest risk: the value trap — cheapness and yield that keep drifting lower as the business erodes.
This verdict is logged as a tracked Synthos call as of 2026-07-03 at $25.37.
Provenance & disclosures
- Traceability: 0 KB claims, breadth 0 — no expert coverage exists for KHC in the Synthos knowledge base, so no
claim_ids are cited (none exist). Per house standard, no conviction was manufactured; the verdict is fundamentals- and quant-driven only. - Data as-of: fundamentals 2026-03-28 (Q1'26) · estimates & prices 2026-07-02/03. Forward figures are analyst consensus (FMP), labeled as estimates.
- GAAP caveat: FY25 GAAP EPS (−$4.93) reflects a ~$9B+ non-cash brand impairment; valuation and cash-flow analysis use FCF and adjusted/consensus forward EPS, clearly labeled.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").